Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
76
days
An evaluation of marnetegragene autotemcel for the treatment of severe leukocyte adhesion deficiency type I
Authors
Jenni Fleischauer; Michael Rothe; Teng Cheong Ha; Axel SchambachShow moreShow less
Affiliations
1. Hannover Medical School; 2. Dana-Farber Cancer Institute, Harvard Medical SchoolShow moreShow less
97
days
Biologic therapies for adult chronic urticaria: what works, what doesn’t, and why
Authors
Ragıp Ertaş; Muhammed Burak Yücel; Zenon Brzoza; Rabia Öztaş Kara; Aistė Ramanauskaitė; Murat Türk; Yi-Kui Xiang; Emek KocatürkShow moreShow less
Affiliations
1. University of Health Sciences; 2. Memorial Kayseri Hospital; 3. University Hospital; 4. University of Opole; 5. Sakarya University Faculty of Medicine; 6. Charité – Universitätsmedizin Berlin; 7. Erciyes University School of Medicine; 8. Fraunhofer Institute for Translational Medicine and Pharmacology ITMP; 9. Tongji University School of Medicine; 10. Bahçeşehir University School of Medicine, Istanbul, TurkeyShow moreShow less
96
days
Harnessing novel agents to target KRAS-driven pathways in pancreatic cancer
Authors
Joanna Kreidi; Celine Hoyek; Cody Eslinger; Tanios Bekaii-SaabShow moreShow less
Affiliations
1. University of Balamand; 2. Mayo ClinicShow moreShow less
62
days
Dopamine-replacing gene therapy for Parkinson’s disease: biochemical background and current clinical experience
Authors
Hiroshi Ichinose; Yo Sato; Shin-ichi MuramatsuShow moreShow less
Affiliations
1. Department of Pediatrics, Jichi Medical University, Tochigi, Japan; 2. Jichi Medical UniversityShow moreShow less
77
days
Progress in gene therapy for RPGR-associated X-linked retinitis pigmentosa
Authors
Maram E. A. Abdalla Elsayed; Robert E. MacLarenShow moreShow less
Affiliations
1. University of Oxford; 2. Oxford University Hospitals NHS Foundation TrustShow moreShow less
33
days
Threats to validity of the PESTO perispinal etanercept stroke trial: a document-based clinical trial evaluation
Authors
Edward Tobinick; Güven GürbüzShow moreShow less
Affiliations
1. Institute of Neurological Recovery (INR PLLC); 2. RN ClinicsShow moreShow less
FAQ
How long does EXPERT OPINION ON BIOLOGICAL THERAPY take to review a manuscript?
As of 2026-11-19, CrushSCI has 21 complete review records for EXPERT OPINION ON BIOLOGICAL THERAPY. The fastest paper went from submission to acceptance in 33 days (Threats to validity of the PESTO perispinal etanercept stroke trial: a document-based clinical trial evaluation, received 2026-07-19, accepted 2026-08-21); the slowest took 145 days. The average is 76.4 days and the median is 76 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
